Answer
It is classified as an antineoplastic protein kinase inhibitor. It targets JAK1 and JAK2 rather than acting like conventional cytotoxic chemotherapy.
Sources for this answer
- Jakavi 5mg, 10mg, 15mg and 20mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.